Table I.
Amplitudes | Area | Frequency | n | |
---|---|---|---|---|
nM | μm2 | s−1 | ||
Basal | ||||
CD38− | 44.3 ± 17.7 | 0.33 ± 0.08 | ND | 60 |
CD38− preinc. cADPR | 64.3 ± 22.9 | 0.42 ± 0.16 | ND | 98 |
CD38− microinj. Ry | 45.6 ± 18.2 | 0.36 ± 0.09 | ND | 60 |
CD38+ | 52.1 ± 14.9 | 0.34 ± 0.08 | ND | 91 |
ATP | ||||
CD38− | 50.1 ± 15.3 | 0.34 ± 0.07 | 0.40 ± 0.39 | 78 |
CD38− preinc. cADPR | 98.4 ± 29.6a | 0.38 ± 0.14 | 1.13 ± 0.51a | 111 |
CD38− microinj. Ry | 87.2 ± 26.2a | 0.36 ± 0.10 | 1.71 ± 0.66a | 106 |
CD38+ | 96.0 ± 36.7a | 0.35 ± 0.09 | 1.23 ± 0.42a | 131 |
Confocal Ca2+ imaging in single Fura2-loaded 3T3 cells was carried out as described in the Materials and methods. During the basal period, images were acquired at low temporal resolution; thus, the frequency of signals was not determined (ND). Subcellular Ca2+ signals were analyzed in the first seconds upon ATP stimulation in 13–18 ROIs from three cells for each condition (n, number of individual signals analyzed in total for each condition). For the subcellular distribution of the subcellular signals, refer to Fig. 5. Data are presented as mean ± SD.
Statistically significant differences versus CD38− cells (P ≤ 0.05, t test).